{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:04:08Z","timestamp":1790697848610,"version":"4.1.0"},"reference-count":40,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"unspecified","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2026,7,31]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Investigate the role of antiphospholipid antibodies (aPL) in determining subclinical microvascular alterations in patients with primary antiphospholipid syndrome (PAPS) and antiphospholipid carriers, using posterior segment optical coherence tomography angiography (OCTA) and spectral-domain OCT (SD-OCT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this monocentric, cross-sectional study, PAPS and aPL-carrier patients and age-matched and sex-matched healthy controls were enrolled. OCTA and OCT were performed to assess vessel density (VD) in the superficial and deep retinal capillary plexi and to obtain high-resolution sectional retinal images.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>38\u2009patients from the aPL-cohort (30 PAPS and 8 aPL-carriers) and 32 matched healthy controls were enrolled. OCTA revealed reduced superficial and deep whole en face VD, particularly at the parafoveal level. SD-OCT demonstrated thinning of the central and outer regions of peripapillary retinal nerve fibre layer and of the macular, inner and outer plexiform, nuclear and nerve fibre layers. Increased thickness was observed in the inner inferior and superior regions across all retinal layers. No significant associations were found between OCTA parameters and disease duration, thrombotic risk profile, lupus anticoagulant positivity, cumulative drug exposure or treatments with low-dose aspirin or vitamin K antagonists. However, the VD in the superficial whole en face and parafoveal regions remained significantly reduced in the aPL-cohort after adjustment for age and cardiovascular risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Subclinical microvascular and structural damage occurs in aPL positive patients without ocular symptoms. This study suggests a possible independent effect of aPL, making the eye a unique, non-invasive window into aPL-related pathogenic mechanisms for early detection and longitudinal monitoring.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/lupus-2026-002075","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:00:16Z","timestamp":1786971616000},"page":"e002075","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Subclinical ocular microvascular involvement in primary antiphospholipid syndrome and antiphospholipid antibody carriers"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4963-0663","authenticated-orcid":false,"given":"Maria","family":"Iacovantuono","sequence":"first","affiliation":[{"name":"Rheumatology, Allergology and Clinical Immunology, Department of System Medicine, University of Rome Tor Vergata, Rome, Lazio, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Nesi","sequence":"additional","affiliation":[{"name":"Ophthalmology, Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Iuliano","sequence":"additional","affiliation":[{"name":"Ophthalmology, Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ferrigno","sequence":"additional","affiliation":[{"name":"Rheumatology, Allergology and Clinical Immunology, Department of System Medicine, University of Rome Tor Vergata, Rome, Lazio, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Greco","sequence":"additional","affiliation":[{"name":"Rheumatology, Allergology and Clinical Immunology, Department of System Medicine, University of Rome Tor Vergata, Rome, Lazio, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Kroegler","sequence":"additional","affiliation":[{"name":"Rheumatology, Allergology and Clinical Immunology, Department of System Medicine, University of Rome Tor Vergata, Rome, Lazio, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Mancino","sequence":"additional","affiliation":[{"name":"Ophthalmology, Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Martucci","sequence":"additional","affiliation":[{"name":"Ophthalmology, Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Nucci","sequence":"additional","affiliation":[{"name":"Ophthalmology, Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Sole","family":"Chimenti","sequence":"additional","affiliation":[{"name":"Rheumatology, Allergology and Clinical Immunology, Department of System Medicine, University of Rome Tor Vergata, Rome, Lazio, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricard","family":"Cervera","sequence":"additional","affiliation":[{"name":"Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Cesareo","sequence":"additional","affiliation":[{"name":"Ophthalmology, Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7905-8413","authenticated-orcid":false,"given":"Paola","family":"Conigliaro","sequence":"additional","affiliation":[{"name":"Rheumatology, Allergology and Clinical Immunology, Department of System Medicine, University of Rome Tor Vergata, Rome, Lazio, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"2026092908103431000_13.2.e002075.1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198911000-00004"},{"key":"2026092908103431000_13.2.e002075.2","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/art.42624","article-title":"The 2023 ACR\/EULAR Antiphospholipid Syndrome Classification Criteria","volume":"75","author":"Barbhaiya","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"2026092908103431000_13.2.e002075.3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215213"},{"key":"2026092908103431000_13.2.e002075.4","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F"},{"key":"2026092908103431000_13.2.e002075.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01753.x"},{"key":"2026092908103431000_13.2.e002075.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(02)00289-8"},{"key":"2026092908103431000_13.2.e002075.7","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1177\/09612033221133687","article-title":"Ocular findings in asymptomatic patients with primary antiphospholipid syndrome","volume":"31","author":"Neto","year":"2022","journal-title":"Lupus"},{"key":"2026092908103431000_13.2.e002075.8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4103\/meajo.meajo_97_23","article-title":"Ocular Manifestations of Antiphospholipid Syndrome in Jordan","volume":"29","author":"Al-Zubi","year":"2022","journal-title":"Middle East Afr J Ophthalmol"},{"key":"2026092908103431000_13.2.e002075.9","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1177\/0961203320949667","article-title":"Ophthalmologic manifestations in primary antiphospholipid syndrome patients: A cross-sectional analysis of a primary antiphospholipid syndrome cohort (APS-Rio) and systematic review of the literature","volume":"29","author":"Franco","year":"2020","journal-title":"Lupus"},{"key":"2026092908103431000_13.2.e002075.10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/09612033221143294","article-title":"Ocular involvement in primary antiphospholipid syndrome: results of an extensive ophthalmological evaluation performed in the APS-Rio cohort","volume":"32","author":"Franco","year":"2023","journal-title":"Lupus"},{"key":"2026092908103431000_13.2.e002075.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2006.11.005"},{"key":"2026092908103431000_13.2.e002075.12","first-page":"31","article-title":"Retinal vascular lesions in systemic lupus erythematosus and secondary antiphospholipid syndrome","volume":"121","author":"Ermakova","year":"2005","journal-title":"Vestn Oftalmol"},{"key":"2026092908103431000_13.2.e002075.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.01.004"},{"key":"2026092908103431000_13.2.e002075.14","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2016-309389"},{"key":"2026092908103431000_13.2.e002075.15","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2023-000977","article-title":"Relationship between retinal microvascular impairment and subclinical atherosclerosis in SLE","volume":"10","author":"Ferrigno","year":"2023","journal-title":"Lupus Sci Med"},{"key":"2026092908103431000_13.2.e002075.16","first-page":"581","article-title":"Assessment of microvascular involvement in lupus nephritis patients by retinal OCT-angiography and kidney biopsies","volume":"41","author":"Conigliaro","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"2026092908103431000_13.2.e002075.17","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-023-02782-7","article-title":"Subclinical microvascular changes in ANCA-vasculitides: the role of optical coherence tomography angiography and nailfold capillaroscopy in the detection of disease-related damage","volume":"18","author":"Triggianese","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"2026092908103431000_13.2.e002075.18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00296-023-05495-z","article-title":"Peripheral and ocular microvascular alterations in systemic sclerosis: observations from capillaroscopic assessments, perfusion peripheral analysis, and optical coherence tomography angiography","volume":"44","author":"Cutolo","year":"2024","journal-title":"Rheumatol Int"},{"key":"2026092908103431000_13.2.e002075.19","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1093\/rheumatology\/keac626","article-title":"Preclinical ocular changes in systemic lupus erythematosus patients by optical coherence tomography","volume":"62","author":"Pelegr\u00edn","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"2026092908103431000_13.2.e002075.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.01.058"},{"key":"2026092908103431000_13.2.e002075.21","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jtha.2024.10.022","article-title":"An update on laboratory detection and interpretation of antiphospholipid antibodies for diagnosis of antiphospholipid syndrome: guidance from the ISTH-SSC Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibodies","volume":"23","author":"Devreese","year":"2025","journal-title":"J Thromb Haemost"},{"key":"2026092908103431000_13.2.e002075.22","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/jth.14846","article-title":"Lupus anticoagulant detection in anticoagulated patients. Guidance from the Scientific and Standardization Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis","volume":"18","author":"Tripodi","year":"2020","journal-title":"J Thromb Haemost"},{"key":"2026092908103431000_13.2.e002075.23","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14082791","article-title":"Update on the Laboratory Diagnosis of Lupus Anticoagulant: Current Challenges and Clinical Involvement","volume":"14","author":"Marco-Rico","year":"2025","journal-title":"J Clin Med"},{"key":"2026092908103431000_13.2.e002075.24","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214235"},{"key":"2026092908103431000_13.2.e002075.25","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000765"},{"key":"2026092908103431000_13.2.e002075.26","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ophtha.2017.10.029","article-title":"Peripapillary and Macular Vessel Density in Patients with Primary Open-Angle Glaucoma and Unilateral Visual Field Loss","volume":"125","author":"Yarmohammadi","year":"2018","journal-title":"Ophthalmology"},{"key":"2026092908103431000_13.2.e002075.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(00)00884-9"},{"key":"2026092908103431000_13.2.e002075.28","doi-asserted-by":"publisher","DOI":"10.1002\/art.10187"},{"key":"2026092908103431000_13.2.e002075.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2005.10.005"},{"key":"2026092908103431000_13.2.e002075.30","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-022-02814-w","article-title":"Clinical characteristics and prognosis of patients with antiphospholipid antibodies based on cluster analysis: an 8-year cohort study","volume":"24","author":"Qi","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"2026092908103431000_13.2.e002075.31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3928\/23258160-20170130-13","article-title":"Optical Coherence Tomography Angiography of Paracentral Acute Middle Maculopathy Associated With Primary Antiphospholipid Syndrome","volume":"48","author":"Trese","year":"2017","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"2026092908103431000_13.2.e002075.32","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315582285"},{"key":"2026092908103431000_13.2.e002075.33","doi-asserted-by":"crossref","first-page":"823","DOI":"10.21037\/qims-21-359","article-title":"Retinal thickness and microvascular alterations in the diagnosis of systemic lupus erythematosus: a new approach","volume":"12","author":"Liu","year":"2022","journal-title":"Quant Imaging Med Surg"},{"key":"2026092908103431000_13.2.e002075.34","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00201.2016"},{"key":"2026092908103431000_13.2.e002075.35","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14972"},{"key":"2026092908103431000_13.2.e002075.36","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00417-022-05788-2","article-title":"Reproducibility of retinal vessel density among three different OCTA devices in ADOA patients","volume":"261","author":"Lombardo","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2026092908103431000_13.2.e002075.37","doi-asserted-by":"publisher","DOI":"10.2147\/opth.s3361"},{"key":"2026092908103431000_13.2.e002075.38","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2022.1099348","article-title":"Current perspective on retinal remodeling: Implications for therapeutics","volume":"16","author":"Pfeiffer","year":"2022","journal-title":"Front Neuroanat"},{"key":"2026092908103431000_13.2.e002075.39","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/ICU.0b013e328358b937","article-title":"Antiphospholipid antibody syndrome","volume":"23","author":"Yang","year":"2012","journal-title":"Curr Opin Ophthalmol"},{"key":"2026092908103431000_13.2.e002075.40","doi-asserted-by":"crossref","first-page":"102745","DOI":"10.1016\/j.coi.2026.102745","article-title":"Endothelial dysfunction in APS: advancing pathophysiological understanding to improve management","volume":"100","author":"Pericleous","year":"2026","journal-title":"Curr Opin Immunol"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2026-002075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:15:26Z","timestamp":1790694926000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2026-002075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,8,17]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/lupus-2026-002075"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2026-002075","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}